Recombinant Human Anti-PD-1 Monoclonal Antibody HX008 Injection for the Treatment of Advanced Solid Tumors

NCT03704246 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: Anti-PD-1 monoclonal antibody

Sponsor

Taizhou Hanzhong biomedical co. LTD